Literature DB >> 1696012

RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator.

G J Graham1, J J Maio.   

Abstract

Tandem repeats of the transactivation response element (TAR) of the human immunodeficiency virus 1 (HIV-1) were generated using a specially constructed "tandemizing" plasmid, pGem-Tan. This plasmid exploits the rotational nonequivalence of Ava I restriction sites to generate multiple copies of an inserted sequence. Twelve tandem repeats of the TAR were then placed in sense and antisense orientations behind a strong human beta-actin gene promoter. The TAR constructs were transfected with an appropriate HIV-1-driven reporter and tat gene expression plasmids into NT2/D1 cells, a pluripotential human embryonic teratocarcinoma cell line. Twelve tandem TAR repeats in the sense orientation suppressed 85-90% of the transactivating function of the virus-encoded tat protein, whereas the antisense construct or constructs containing single copies of TAR in either sense or antisense orientations were relatively ineffective. The suppression was specific for reporter gene constructs containing an intact HIV-1 long terminal repeat: Reporter genes driven by other promoters or by an HIV-1 long terminal repeat lacking the TAR were not suppressed. Suppression of activation by tat required transcription into RNA: Similar constructs containing the TAR repeats but lacking a eukaryotic promoter failed to suppress tat activation. In the absence of tat, the TAR DNA stimulated 2- to 5-fold the expression of gene constructs driven not only by the HIV-1 long terminal repeat but also by the human beta-actin gene and the simian virus 40 promoters.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696012      PMCID: PMC54419          DOI: 10.1073/pnas.87.15.5817

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  In vivo competition between a metallothionein regulatory element and the SV40 enhancer.

Authors:  H Scholer; A Haslinger; A Heguy; H Holtgreve; M Karin
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

2.  Competitive and cooperative functioning of the anterior and posterior promoter elements of an Alu family repeat.

Authors:  C Perez-Stable; C K Shen
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

3.  Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat.

Authors:  J Sodroski; C Rosen; F Wong-Staal; S Z Salahuddin; M Popovic; S Arya; R C Gallo; W A Haseltine
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

4.  Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.

Authors:  P C Zamecnik; J Goodchild; Y Taguchi; P S Sarin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: a novel translational control mechanism.

Authors:  I Edery; R Petryshyn; N Sonenberg
Journal:  Cell       Date:  1989-01-27       Impact factor: 41.582

6.  Structural arrangements of transcription control domains within the 5'-untranslated leader regions of the HIV-1 and HIV-2 promoters.

Authors:  K A Jones; P A Luciw; N Duchange
Journal:  Genes Dev       Date:  1988-09       Impact factor: 11.361

7.  A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats.

Authors:  S Gendler; J Taylor-Papadimitriou; T Duhig; J Rothbard; J Burchell
Journal:  J Biol Chem       Date:  1988-09-15       Impact factor: 5.157

8.  DNA strand reassociation and polyribonucleotide binding in the African green monkey, Cercopithecus aethiops.

Authors:  J J Maio
Journal:  J Mol Biol       Date:  1971-03-28       Impact factor: 5.469

9.  Regulation of expression driven by human immunodeficiency virus type 1 and human T-cell leukemia virus type I long terminal repeats in pluripotential human embryonic cells.

Authors:  J J Maio; F L Brown
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

10.  Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

Authors:  S K Arya; C Guo; S F Josephs; F Wong-Staal
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

View more
  16 in total

1.  Inhibition of transcription by the TAR RNA of HIV-1 in a nuclear extract of HeLa cells.

Authors:  R Yamamoto; S Koseki; J Ohkawa; K Murakami; S Nishikawa; K Taira; P K Kumar
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

Review 2.  Cell-based gene therapy against HIV.

Authors:  R Dey; B Pillai
Journal:  Gene Ther       Date:  2015-06-16       Impact factor: 5.250

3.  Juxtaposition between activation and basic domains of human immunodeficiency virus type 1 Tat is required for optimal interactions between Tat and TAR.

Authors:  Y Luo; B M Peterlin
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

4.  Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1.

Authors:  A Alonso; T P Cujec; B M Peterlin
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

5.  Characterization of a "kissing" hairpin complex derived from the human immunodeficiency virus genome.

Authors:  K Y Chang; I Tinoco
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

6.  Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.

Authors:  S W Lee; H F Gallardo; E Gilboa; C Smith
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  RNA-targeted activators, but not DNA-targeted activators, repress the synthesis of short transcripts at the human immunodeficiency virus type 1 long terminal repeat.

Authors:  P S Pendergrast; N Hernandez
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

8.  Inducible transcriptional activation of the human immunodeficiency virus long terminal repeat by protein kinase inhibitors.

Authors:  F L Brown; E Tahaoglu; G J Graham; J J Maio
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

9.  Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells.

Authors:  Y Luo; S J Madore; T G Parslow; B R Cullen; B M Peterlin
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression.

Authors:  Koh Fujinaga; Dan Irwin; Matthias Geyer; B Matija Peterlin
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.